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Rett syndrome (RTT) is an X-linked postnatal neuro-
developmental disorder, which is primarily caused by
mutations in the gene encoding methyl-CpG binding
protein 2 (MeCP2). A number of MeCP2 target genes
have been identified, including the neurotrophic factor
BDNF; however, the functional relevance of these tar-
gets has not been established. In this issue of Neuron,
Chang et al. provide the first in vivo evidence for
a functional interaction between BDNF and MeCP2.
Rett syndrome (RTT) is an X-linked neurodevelopmental
disorder. About 80% of the patients carry mutations in
a gene located on the X chromosome, encoding a
methyl-CpG binding protein, MeCP2 (Amir et al., 1999).
This disorder is almost exclusively diagnosed in young
females because males carrying similar mutations often
die perinatally with severe congenital encephalopathy.
After apparently normal development for 6–18 months,
RTT patients show regression of head growth and loss
of speech and acquired motor skills. Purposeful hand
use is replaced by stereotypic hand-wringing move-
ments. Patients display breathing irregularities, ataxia,
seizures, scoliosis/kyphosis, autistic behavior, and se-
vere mental retardation (Hagberg et al., 1983). Despite
these symptoms, with proper care, RTT patients often
survive into adulthood. Interestingly, after the initial cri-
sis associated with the onset of the RTT symptoms, no
further regression is apparent, suggesting that the con-
dition does not involve progressive neurodegeneration.
Before the discovery of Mecp2 as the primary disease
gene for RTT, MeCP2 was known to bind to methylated
DNA at methyl-CpG sites. MeCP2 binding translates
DNA methylation into a gene-silencing signal by recruit-
ing inactive chromatin remodeling complexes including
histone deacetylases (HDACs) and histone H3 lysine 9
methyltransferases (H3K9-HMTs) (Fuks et al., 2003;
Nan et al., 1998). MeCP2 contains two major functional
domains, the methyl-CpG binding domain (MBD) and
the transcriptional repression domain (TRD). A number
of RTT mutations of MeCP2 have been found to cluster
within either the MBD or TRD regions, which in most
cases, render MeCP2 incapable of binding to methyl-
ated DNA and/or repressing gene transcription. Mouse
knockout studies on MeCP2 further support the notion
that loss-of-function mutations of Mecp2 represent the
primarily cause of RTT (Chen et al., 2001; Guy et al.,
2001). However, more recent studies on the R168X (trun-
cation) mutation ofMecp2 as well asMecp2 overexpres-
sion transgenic mice indicated that enhanced Mecp2
function or methyl-CpG binding affinity could also lead
to neurological dysfunction related to RTT (Collins
et al., 2004).
The attempts to reveal RTT etiology simply from loss
of MeCP2 function in transcription repression have cre-
ated some surprises. Efforts toward identification ofgenes repressed by MeCP2 by gene expression profil-
ing yielded almost no significant results, which led to
the conclusion that MeCP2 is not a global gene repres-
sor (Tudor et al., 2002). One potential caveat of the ap-
proach taken is the heterogeneity of brain tissue, which
contains many different types of neurons, glia, as well as
cells of nonneural origin. It is likely that MeCP2 regulates
different sets of genes in different cell types. Therefore
using whole brain would significantly mask cell-type-
specific changes in gene expression that result from
MeCP2 deficiency. By using chromatin immunoprecipi-
tation (ChIP) as well as gene expression analyses on
Mecp2+/y and Mecp22/y perinatal mouse cortical cul-
tures that are less heterogeneous, the first mamma-
lian neuronal target gene for MeCP2 was identified—
brain-derived neurotrophic factor (Bdnf) (Chen et al.,
2003; Martinowich et al., 2003). Subsequently, Dlx5 and
several glucocorticoid-regulated genes were discov-
ered as MeCP2 targets (Horike et al., 2005; Nuber
et al., 2005). However, whether misregulation of these
genes due to MeCP2 deficiency contributes, in any
aspect, to RTT remains to be determined.
In this issue of Neuron, Chang et al. (2006) provide
in vivo evidence for a functional interaction between
BDNF and MeCP2. The story begins with a surprise,
i.e., BDNF protein levels decrease in Mecp22/y cortex,
cerebellum, and the rest of the brain, respectively, by
21%, 41%, and 55% of wild-type levels. Because Bdnf
is a target of repression by MeCP2, it is somewhat un-
expected that BDNF levels decrease in the absence of
MeCP2.
Three years ago, Chen et al. demonstrated that in neo-
natal MeCP22/y mouse cortical cultures with neuronal
activity blocked by TTX, there was an approximately
2-fold increase in the Bdnf exon IV(equivalent to rat
Bndf exon III)-specific mRNA as compared to wild-
type cultures (Chen et al., 2003). Given that these corti-
cal cultures contain BDNF-expressing glutamatergic ex-
citatory neurons, GABAergic-inhibitory neurons, which
do not express BDNF even in the absence of MeCP2,
and low levels cortical astrocytes/progenitors, this
2-fold increase likely underestimates the increase that
would be observed from a population of pure resting ex-
citatory neurons. In addition, because mouse Bndf can
be transcribed from five different exon-specific pro-
moters, it is unclear how this 2-fold increase in exon IV-
specific mRNA affects the total mRNA and protein levels
of BDNF.Bdnf is known to be robustly upregulated in re-
sponse to neuronal activity. Thus, the reduction in over-
all cortical neuronal activity seen in Mecp22/y mice is
expected to affect Bdnf expression dramatically. This
additional effect would override the increase in Bdnf
basal transcription that results from lack of repression
in resting cortical neurons because of MeCP2 deficiency
(Figure 1).
It is worth mentioning that the reduction in Bdnf ex-
pression is not observed in 2 week oldMecp22/y cortices
in which decreased firing of layer V neurons is already ap-
parent, suggesting that downregulation ofBDNF isa later
and indirect outcome of MeCP2 deficiency. Although it
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322Figure 1. Cell-Autonomous and -Nonautonomous Functions of MeCP2 in Bndf Regulation and a Functional Interaction between MeCP2 and
BDNF
In restingMecp2+/y layer V neurons, BDNF exon IV promoter is repressed by the MeCP2/mSin3A/HDAC complex, which dissociates from the pro-
moter after neuronal activity and is replaced by a transcriptional activation complex that includes CREB and CBP/p300. In restingMecp22/y neu-
rons, the BDNF exon IV promoter is derepressed. However, without neuronal activity, no robust activation of the promoter can be detected. In
Mecp22/y cortices, neuronal activity decreases. Even though the promoter is derepressed because of MeCP2 deficiency, it can only be moder-
ately activated because of decreased neuronal activity. In the case of BDNF overexpression, restored cortical neuronal activity potentially leads
to a reversal of endogenous BDNF expression. It is currently unclear how MeCP2 and BDNF coordinately regulate neuronal activity.wouldn’t be surprising that the 30% decrease in the over-
all brain BDNF levels may contribute to the later disease
progression of RTT, there is currently no evidence indi-
cating that the direct and/or indirect regulation of
BDNF by MeCP2 contributes to RTT etiology.
Elegant mouse genetic approaches enabled Chang
et al. to convincingly demonstrate that forebrain-
specific knockout of the Bdnf gene in Mecp22/y mice
exacerbated the RTT-like phenotypes. Remarkably,
forebrain-specific overexpression of BDNF rescued
a subset of RTT-like phenotypes in Mecp22/y mice, in-
cluding reduced lifespan, reduced motor activity, and
reduced layer V neuronal firing frequency. These find-
ings strongly suggest that there is a functional interac-
tion between MeCP2 and BDNF and that brain BDNF
levels can modulate RTT disease progression.
Chang et al. also report that the forebrain-specific
knockout of Bdnf mimicked a subset of the phenotypes
observed in the Mecp2 knockout, including reduced
brain weight, reduced olfactory and hippocampal neu-
ronal sizes, and hindlimb clasping. However, overex-
pression of Bdnf has not been shown to effectively res-
cue these phenotypes shared by the two knockouts. In
contrast, the phenotypes of Mecp22/y mice that can
be rescued by BDNF are not detectable in Bdnf knock-
out. Therefore, it is likely that BDNF has widespread
neuromodulatory effects throughout the brain, some
but not all of which overlap with MeCP2 function. A fu-
ture mechanistic insight into the functional interaction
between BDNF and MeCP2 will advance our under-
standing of RTT etiology.
Several new approaches and issues are currently
emerging regarding RTT research: (1) cell-type-specific
gene regulation by MeCP2 will soon be revealed bygene-expression studies with Mecp2 loss- and gain-
of-function transgenic mice together with neuronal sub-
type lineage labeling technologies; (2) genome-wide
ChIP-on-chip technology with improved MeCP2 anti-
bodies or epitope-tagged MeCP2 knockin mice, or cul-
tured neuronal cells will help identify MeCP2 binding tar-
gets, which may or may not change expression upon
Mecp2 deletion; (3) more studies will be focused on
posttranscriptional regulation of synaptic transmission
by MeCP2; and (4) more attempts will be made to deter-
mine the role of the MeCP2 deficiency-induced imbal-
ance between excitatory (glutamatergic) and inhibitory
(GABAergic) circuitries in RTT. Finally, it has been shown
that Mecp2 null male mice (Mecp22/y) display symp-
toms similar to RTT female patients and female Mecp2
heterozygote mice (Mecp2+/2) display much more sub-
tle neurological deficits, demonstrating a significant dif-
ference between mouse models and human patients.
Therefore, human cell-culture models for RTT may con-
tribute important complementary information to our un-
derstanding of the disease.
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that local translation in neurites is important for the de-
velopment and plasticity of neural circuits. It is worth
noting that local translation requires the presence of
mRNA, ribosomes, and translational machinery at neu-
rites, which is likely to depend on molecular motor-
based intracellular trafficking.
Classic experiments performed by Oswald Steward
and colleagues showed that polyribosomes were selec-
tively localized beneath postsynaptic sites in the den-
drites of CNS neurons (Steward, 1983; Steward and
Fass, 1983; Steward and Levy, 1982). Later studies
showed that both mRNA and translation machinery
were present at dendritic spines (reviewed by Steward
and Schuman, 2001). The presence of particular tran-
scripts in axonal growth cones and their importance in
axon guidance have also been suggested (Brittis et al.,
2002; Campbell and Holt, 2001). Still, many questions re-
garding mRNA localization and function at synapses
have not been clearly addressed. For example, at what
point in time does a particular mRNA localize to synap-
ses during the course of synapse formation and matura-
tion? What developmental events trigger this clustering
at synapses? Is the increased concentration of mRNA at
synapses due to redistribution of preexisting mRNA or
due to new transcription? Finally, is synaptic mRNA re-
quired for synapse formation? In this study, Lyles et al.
(2006) presented an elegant set of experiments to ad-
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Local Translation and Synapse
Formation in Cultured
Aplysia Neurons
Synapse formation is initiated by cell-cell contact be-
tween appropriate pre- and postsynaptic cells and is
followed by recruitment of protein complexes in both
pre- and postsynaptic compartments. In this issue of
Neuron, Lyles et al. show that in cultured Aplysia neu-
rons, clustering of an mRNA at nascent synapses is
not only induced by the recognition between synaptic
partners, but is also required for further synaptic de-
velopment and maintenance.
Neurons are large, highly differentiated cells with com-
plex morphologies. Synapses, the business ends of
neurons, are frequently localized in distal neurites, far
away from the cell body. How do distal neurites acquire
and maintain the repertoire of proteins that are required
for synaptic function? In many cases, passive diffusion
is not fast enough to efficiently deliver proteins and or-
ganelles to synapses due to the great distance between
the neuronal cell body and distal neurites. Two active
mechanisms have been proposed to supply the distal
compartments with their constituents. First, protein
may be synthesized in the cell body and transported to
distal neurites. A large family of molecular motors traffic
cytosolic components and organelles back and forth
between neurites and the cell body (Vale, 2003). Alterna-
tively, protein synthesis may take place locally in neu-
rites. A growing body of evidence supports the notion
dress these questions while studying the neuropeptide
sensorin.
In culture, Aplysia neurons form functional synapses,
whose activity can be readily measured with electro-
physiology. Remarkably, synapse formation in vitro
maintains target specificity found in intact animals,
whereby isolated Aplysia sensory neurons preferentially
form synapses onto the motor neurons that are their nat-
ural postsynaptic partners. These features, combined
with the ability to perform RNA interference and in situ
hybridization experiments, make cultured Aplysia neu-
rons an ideal system for testing mRNA localization and
function at synapses. The authors found sensorin tran-
script in a cDNA library from isolated processes of sen-
sory neurons. Consistent with previous reports, they
found that sensorin mRNA is localized in distal neurites
(Brunet et al., 1991). More specifically, they reported that
sensorin mRNA is particularly concentrated at presyn-
aptic sites. Furthermore, this clustering effect is most ef-
ficiently induced when the appropriate target neurons
are cocultured, suggesting that recognition between
synaptic partners triggers mRNA localization at synap-
ses.
Next, the authors analyzed the mechanism of sensorin
mRNA localization by asking whether the clustering of
mRNA is due to redistribution of existing mRNA or syn-
thesis of new mRNA. Surprisingly, they found that a tran-
scriptional inhibitor, actinomycin D, blocks synaptic ac-
cumulation of sensorin mRNA. This result implies that
the synaptically localized sensorin mRNA is a new pop-
ulation of mRNA that is induced by synapse formation
signals. It also suggests that there must be differences
between the newly synthesized mRNA and the preexist-
ing mRNA to aid the selective accumulation of new
mRNA at synapses. Therefore, signals generated by na-
scent synapses must travel to the nucleus to stimulate
the transcription of sensorin. The newly synthesized
